Rheumatoid Arthritis and Anti-Tumor Necrosis Factor

Links shared publicly online about this topic

Anti-Tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In RA Patients

medicalnewstoday.com — “A recent study by swedish researchers found that rheumatoid arthritis (ra) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (tnf)View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 30, 2009 at 10:34 am By:

mnt_arthritis MNT Arthritis News Health News

Anti-Tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In RA Patients: A recent study by Swedish re.. http://bit.ly/vplmZ

3 years ago...

Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients

physorg.com — “A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy. The research team, led by Johan Askling, M.D., Ph.D., from Karolinska University Hospital in Stockholm, ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on October 29, 2009 at 2:38 pm By:

FightCancer FightCancer Health News

Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients http://bit.ly/2uatu1

3 years ago...

Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients

eurekalert.org — “A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first six years after starting anti-tumor necrosis factor therapy. Details of the study appear in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology published by Wiley-Blackwell.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on October 29, 2009 at 4:30 am By:

eurekalert science news Health News

AAAS Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients http://bit.ly/E9vuC

3 years ago...

Rheumatology Article | Tumor Necrosis Factors Arthritis, Rheumatoid

mdlinx.com — “Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: Observations from the RADIUS RegistryView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 20, 2011 at 6:20 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: Obser... http://bit.ly/mtMyQD #Rheumatology

1 year ago...

Rheumatology Article | Tumor Necrosis Factor-alpha Arthritis, Rheumatoid

mdlinx.com — “Improved sleep efficiency after anti-tumor necrosis factor {alpha} therapy in rheumatoid arthritis patientsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 5:32 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Improved sleep efficiency after anti-tumor necrosis factor {alpha} therapy in rheumatoid arthritis... http://t.co/9S2xHBT #Rheumatology

9 months ago...

Rheumatoid Arthritis - Weight Loss, Tumor Necrosis Factor and Rheumatoid Arthritis

healthcentral.com — “It’s April, finally!!  Spring has arrived and it’s time to start shedding the big coats and bulky sweaters.  The leaves of my lilac bushes...View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on April 5, 2010 at 6:26 pm By:

LisaEmrich Lisa Emrich Patient Expert

Weight Loss, Tumor Necrosis Factor and RA - It’s April, finally!!  Spring has arrived and it’s tim... http://ow.ly/16Z976

2 years ago...

Rheumatology Article | Arthritis, Rheumatoid Tumor Necrosis Factors

mdlinx.com — “Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosionView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 14, 2011 at 8:30 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is ... http://bit.ly/jXgQfT #Rheumatology

11 months ago...

Rheumatology Article | Arthritis, Rheumatoid Tumor Necrosis Factors

mdlinx.com — “Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II trialView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 1, 2011 at 5:41 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis facto... http://bit.ly/hpDLrV #Rheumatology

1 year ago...

Rheumatology Article | Tumor Necrosis Factors Arthritis, Rheumatoid

mdlinx.com — “Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritisView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on December 10, 2010 at 6:45 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among... http://bit.ly/dNJQzG #Rheumatology

1 year ago...

Rheumatology Article | Tumor Necrosis Factors Arthritis, Rheumatoid

mdlinx.com — “Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate source of interleukin 22 and tumor necrosis factor-î±View full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 25, 2011 at 10:25 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate ... http://bit.ly/nATC8O #Rheumatology

10 months ago...

Rheumatology Article | Arthritis, Rheumatoid Tumor Necrosis Factors

mdlinx.com — “Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: Pooled data from 10 European registriesView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 23, 2011 at 9:20 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arth... http://bit.ly/kkEurD #Rheumatology

1 year ago...

Rheumatology Article | Tumor Necrosis Factors Arthritis, Rheumatoid

mdlinx.com — “Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics RegisterView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on February 22, 2011 at 6:37 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rh... http://bit.ly/h8yGw0 #Rheumatology

1 year ago...

Rheumatology - Rheumatoid Arthritis Article | Methotrexate Tumor Necrosis Factors Arthritis, Rheumatoid

mdlinx.com — “Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trialView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 9, 2011 at 7:56 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

TY! RT @Raoutlook: #rheumatology | rituximab in combo w/anti-TNF & MTX: controlled trial for active RA. http://bit.ly/dSITmg

1 year ago...

Rheumatology Medical News about Arthritis, Rheumatoid Tumor Necrosis Factor-alpha

mdlinx.com — “Golimumab, a new human anti-tumor necrosis factor [alpha] antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlledView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 1, 2010 at 11:56 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

#Rheumatology Golimumab, a new human anti-tumor necrosis factor [alpha] antibody, administered intravenously in pa... http://bit.ly/dhkXb3

2 years ago...

Rheumatology Article | Arthritis, Juvenile Rheumatoid Tumor Necrosis Factors

mdlinx.com — “Clinical outcomes after withdrawal of anti-tumor necrosis factor-alpha therapy in juvenile idiopathic arthritis: A twelve-year experienceView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 27, 2011 at 3:18 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Clinical outcomes after withdrawal of anti-tumor necrosis factor-alpha therapy in juvenile idiopat... http://bit.ly/m567uW #Rheumatology

11 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390